Mission Produce And Two Other Stocks Estimated To Be Trading Below Intrinsic Value

Over the last 7 days, the United States market has risen by 1.0%, contributing to an impressive 18% climb over the past year, with earnings forecasted to grow by 17% annually. In this context of robust market performance, identifying stocks that are trading below their intrinsic value can offer investors opportunities for potential appreciation while aligning with current growth trends.

Top 10 Undervalued Stocks Based On Cash Flows In The United States

Name	Current Price	Fair Value (Est)	Discount (Est)
Workday (WDAY)	$175.29	$343.71	49%
Tempus AI (TEM)	$54.61	$108.06	49.5%
Symbotic (SYM)	$41.19	$79.59	48.3%
OceanFirst Financial (OCFC)	$19.15	$38.07	49.7%
Natera (NTRA)	$315.96	$607.68	48%
Lumentum Holdings (LITE)	$932.47	$1844.13	49.4%
HawkEye 360 (HAWK)	$24.73	$48.00	48.5%
Haemonetics (HAE)	$91.34	$175.73	48%
Fluence Energy (FLNC)	$13.20	$26.05	49.3%
Advanced Energy Industries (AEIS)	$337.32	$655.09	48.5%

Click here to see the full list of 134 stocks from our Undervalued US Stocks Based On Cash Flows screener.

Let's dive into some prime choices out of the screener.

Mission Produce (AVO)

Overview: Mission Produce, Inc. operates in the sourcing, farming, packaging, marketing, and distribution of avocados, mangoes, and blueberries for food retailers, wholesalers, and foodservice customers both in the United States and internationally with a market cap of approximately $1.14 billion.

Operations: The company's revenue segments include Blueberries at $92.80 million, International Farming at $126.90 million, and Marketing & Distribution at $1.13 billion.

Estimated Discount To Fair Value: 16.6%

Mission Produce's stock is trading at US$12.74, below its estimated future cash flow value of US$15.28, suggesting undervaluation. Despite recent financial challenges including a net loss of US$7.2 million in Q2 2026 and shareholder dilution, earnings are forecast to grow significantly at 82.26% annually over the next three years, outpacing the market average. The company has initiated a share buyback program worth up to US$100 million to capitalize on perceived undervaluation.

• According our earnings growth report, there's an indication that Mission Produce might be ready to expand.
• Click here to discover the nuances of Mission Produce with our detailed financial health report.

Xeris Biopharma Holdings (XERS)

Overview: Xeris Biopharma Holdings, Inc. is a commercial-stage biopharmaceutical company based in Illinois that develops and commercializes therapies for chronic endocrine and neurological diseases, with a market cap of approximately $1.53 billion.

Operations: The company's revenue is primarily derived from its pharmaceuticals segment, totaling $335.41 million.

Estimated Discount To Fair Value: 47%

Xeris Biopharma Holdings is trading at US$8.49, significantly below its estimated future cash flow value of US$16.02, highlighting potential undervaluation. Despite a net loss increase to US$31.1 million in Q2 2026, revenue rose to US$92.1 million from the previous year’s US$71.54 million. With projected annual earnings growth of 55.93% and expectations of becoming profitable within three years, Xeris's revenue guidance for 2026 is set between $385 million and $390 million.

• Our expertly prepared growth report on Xeris Biopharma Holdings implies its future financial outlook may be stronger than recent results.
• Dive into the specifics of Xeris Biopharma Holdings here with our thorough financial health report.

Gold Royalty (GROY)

Overview: Gold Royalty Corp. is a precious metals-focused royalty company offering financing solutions to the metals and mining industry across several countries, with a market cap of approximately $715.89 million.

Operations: The company's revenue segment consists of $22.56 million from its investment in royalty and mineral stream interests.

Estimated Discount To Fair Value: 25.8%

Gold Royalty is trading at US$3.17, below its estimated future cash flow value of US$4.27, suggesting undervaluation. The company has turned profitable this year with Q2 sales increasing to US$6.73 million from US$3.82 million a year ago and net income reaching US$1.78 million from a previous loss. With projected earnings growth of 73.9% annually and disciplined acquisition strategies, it remains focused on enhancing cash flow through strategic royalties acquisitions.

• Our comprehensive growth report raises the possibility that Gold Royalty is poised for substantial financial growth.
• Delve into the full analysis health report here for a deeper understanding of Gold Royalty.

Make It Happen

• Delve into our full catalog of 134 Undervalued US Stocks Based On Cash Flows here.
• Have you diversified into these companies? Leverage the power of Simply Wall St's portfolio to keep a close eye on market movements affecting your investments.
• Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free.

Contemplating Other Strategies?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com